Squarepoint’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.82M | Sell |
42,293
-169,310
| -80% | -$15.5M | ﹤0.01% | 1706 |
|
|
2025
Q4 | $19M | Buy |
211,603
+174,683
| +473% | +$16.6M | 0.02% | 760 |
|
|
2025
Q3 | $3.64M | Sell |
36,920
-22,694
| -38% | -$2.25M | ﹤0.01% | 1651 |
|
|
2025
Q2 | $5.44M | Buy |
59,614
+52,845
| +781% | +$5.11M | 0.01% | 1405 |
|
|
2025
Q1 | $766K | Sell |
6,769
-58,231
| -90% | -$6.23M | ﹤0.01% | 2889 |
|
|
2024
Q4 | $6.87M | Sell |
65,000
-58,623
| -47% | -$6.29M | 0.01% | 1397 |
|
|
2024
Q3 | $13.3M | Buy |
123,623
+55,413
| +81% | +$6.05M | 0.02% | 805 |
|
|
2024
Q2 | $7.4M | Buy |
68,210
+62,543
| +1,104% | +$7.37M | 0.01% | 1114 |
|
|
2024
Q1 | $748K | Sell |
5,667
-108,883
| -95% | -$13.6M | ﹤0.01% | 2785 |
|
|
2023
Q4 | $13.9M | Buy |
114,550
+67,806
| +145% | +$7.57M | 0.03% | 746 |
|
|
2023
Q3 | $5.25M | Buy |
46,744
+38,751
| +485% | +$4.92M | 0.01% | 1151 |
|
|
2023
Q2 | $1.16M | Buy |
+7,993
| New | +$1.09M | ﹤0.01% | 2050 |
|
|
2022
Q1 | – | Sell |
-37,405
| Closed | -$4.61M | – | 3632 |
|
|
2021
Q4 | $4.61M | Buy |
37,405
+33,209
| +791% | +$4.35M | 0.01% | 830 |
|
|
2021
Q3 | $596K | Sell |
4,196
-45,733
| -92% | -$6.73M | ﹤0.01% | 1854 |
|
|
2021
Q2 | $7.8M | Buy |
49,929
+45,244
| +966% | +$7.33M | 0.03% | 548 |
|
|
2021
Q1 | $728K | Sell |
4,685
-116,684
| -96% | -$18.1M | ﹤0.01% | 1749 |
|
|
2020
Q4 | $18.2M | Buy |
121,369
+102,768
| +552% | +$14.5M | 0.14% | 136 |
|
|
2020
Q3 | $2.46M | Sell |
18,601
-19,735
| -51% | -$2.58M | 0.03% | 561 |
|
|
2020
Q2 | $4.44M | Sell |
38,336
-22,263
| -37% | -$2.57M | 0.07% | 369 |
|
|
2020
Q1 | $5.95M | Buy |
+60,599
| New | +$7.94M | 0.15% | 155 |
|
|
2019
Q4 | – | Sell |
-54,625
| Closed | -$7.28M | – | 2868 |
|
|
2019
Q3 | $7.28M | Sell |
54,625
-274,711
| -83% | -$35.5M | 0.07% | 367 |
|
|
2019
Q2 | $37.6M | Buy |
329,336
+293,183
| +811% | +$34.3M | 0.37% | 50 |
|
|
2019
Q1 | $4.48M | Sell |
36,153
-71,476
| -66% | -$8.12M | 0.05% | 480 |
|
|
2018
Q4 | $10.8M | Buy |
107,629
+95,784
| +809% | +$10.8M | 0.13% | 202 |
|
|
2018
Q3 | $1.51M | Sell |
11,845
-92,567
| -89% | -$11M | 0.02% | 817 |
|
|
2018
Q2 | $11.3M | Sell |
104,412
-36,832
| -26% | -$4.01M | 0.15% | 194 |
|
|
2018
Q1 | $15M | Buy |
+141,244
| New | +$16.4M | 0.24% | 108 |
|
|
2017
Q4 | – | Sell |
-155,497
| Closed | -$17.7M | – | 2377 |
|
|
2017
Q3 | $17.7M | Buy |
155,497
+83,121
| +115% | +$9.59M | 0.34% | 63 |
|
|
2017
Q2 | $9.02M | Buy |
72,376
+26,188
| +57% | +$3.1M | 0.18% | 136 |
|
|
2017
Q1 | $5.48M | Sell |
46,188
-14,818
| -24% | -$1.68M | 0.15% | 157 |
|
|
2016
Q4 | $6.11M | Buy |
61,006
+47,299
| +345% | +$5.07M | 0.25% | 88 |
|
|
2016
Q3 | $1.73M | Buy |
13,707
+6,268
| +84% | +$774K | 0.11% | 205 |
|
|
2016
Q2 | $869K | Buy |
7,439
+4,897
| +193% | +$554K | 0.05% | 392 |
|
|
2016
Q1 | $263K | Sell |
2,542
-357
| -12% | -$34.5K | 0.02% | 878 |
|
|
2015
Q4 | $289K | Sell |
2,899
-11,287
| -80% | -$1.1M | 0.03% | 811 |
|
|
2015
Q3 | $1.29M | Buy |
14,186
+6,747
| +91% | +$676K | 0.32% | 86 |
|
|
2015
Q2 | $789K | Buy |
7,439
+2,631
| +55% | +$291K | 0.26% | 119 |
|
|
2015
Q1 | $549K | Buy |
+4,808
| New | +$549K | 0.19% | 168 |
|
Other funds holding ZBH
VCM
VPM
Squarepoint's ZBH Position: Q1 2026 in Review
Squarepoint reduced its Zimmer Biomet (ZBH) stake by 80% in Q1 2026, selling an estimated $15.5M and leaving 42,293 shares worth $3.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1706.
Squarepoint first reported a position in ZBH in Q1 2015 and has held it in 38 quarters since. The position peaked at $37.6M in Q2 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Squarepoint held 42,293 shares of Zimmer Biomet worth $3.82M as of Q1 2026.
- Squarepoint sold 169,310 Zimmer Biomet shares in Q1 2026, an estimated $15.5M.
- Zimmer Biomet made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1706 holding.
- Squarepoint first reported a position in Zimmer Biomet in Q1 2015 and has held it in 38 quarters since.
- Squarepoint's Zimmer Biomet position peaked at $37.6M in Q2 2019.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.